Joseph C Cappelleri Selected Research

Sildenafil Citrate (Viagra)

4/2018	Clinically important difference on the Erectile Dysfunction Inventory of Treatment Satisfaction questionnaire in patients with erectile dysfunction.
1/2018	Enriching the Interpretation of the Erectile Dysfunction Inventory of Treatment Satisfaction: Characterizing Success in Treatment Satisfaction.
4/2016	Simplified Interpretation of the Erectile Function Domain of the International Index of Erectile Function.
1/2013	Multi-domain Longitudinal Modeling: An Application to the International Index of Erectile Function.
9/2010	Interrelationship of sildenafil treatment effects on the physiological and psychosocial aspects of erectile dysfunction of mixed or organic etiology.
1/2009	Estimating a minimally important difference in pulmonary arterial hypertension following treatment with sildenafil.
10/2008	The erection hardness score and its relationship to successful sexual intercourse.
4/2008	Analysis of single items on the Self-Esteem and Relationship questionnaire in men treated with sildenafil citrate for erectile dysfunction: results of two double-blind, placebo-controlled trials.
11/2007	Validation of the erection hardness score.
9/2007	Clinically meaningful improvement on the Self-Esteem And Relationship questionnaire in men with erectile dysfunction.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joseph C Cappelleri Research Topics

Disease

26	Pain (Aches) 01/2022 - 06/2009
17	Erectile Dysfunction 04/2018 - 05/2003
15	Neoplasms (Cancer) 01/2021 - 01/2008
13	Psoriatic Arthritis 08/2022 - 11/2018
13	Fibromyalgia (Fibrositis) 01/2018 - 06/2009
12	Atopic Dermatitis (Atopic Eczema) 01/2022 - 04/2019
11	Ulcerative Colitis 04/2022 - 02/2015
11	Fatigue 01/2022 - 06/2014
10	Osteoarthritis 01/2022 - 01/2011
10	Renal Cell Carcinoma (Grawitz Tumor) 06/2019 - 01/2008
9	Psoriasis (Pustulosis Palmaris et Plantaris) 08/2022 - 12/2012
9	Chronic Disease (Chronic Diseases) 01/2022 - 01/2013
8	Pruritus (Itching) 10/2021 - 02/2015
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2022 - 02/2019
5	Peripheral Nervous System Diseases (PNS Diseases) 04/2015 - 03/2012
4	Necrosis 04/2022 - 12/2012
4	Infections 01/2022 - 01/2019
4	Rheumatoid Arthritis 01/2022 - 01/2011
4	Neuralgia (Stump Neuralgia) 01/2021 - 03/2011
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2022 - 08/2019
3	Atrial Fibrillation 01/2022 - 01/2021
3	Hemorrhage 01/2022 - 10/2018
3	Ankylosing Spondylitis 01/2022 - 01/2019
3	Chronic Pain 01/2022 - 01/2017
3	Arthritis (Polyarthritis) 01/2021 - 01/2011
3	Disease Progression 01/2021 - 01/2008
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 11/2016
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2021 - 01/2019
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 01/2018
3	Anxiety Disorders (Anxiety Disorder) 03/2012 - 10/2008
2	Eczema 10/2021 - 06/2021
2	Leukemia 06/2020 - 06/2019
2	Ovarian Neoplasms (Ovarian Cancer) 05/2020 - 01/2018
2	Postmenopausal Osteoporosis 10/2016 - 06/2014
2	Contracture 03/2012 - 11/2011
2	Dupuytren Contracture (Dupuytrens Contracture) 11/2011 - 10/2011
2	Kidney Neoplasms (Kidney Cancer) 09/2011 - 06/2009
2	Sleep Initiation and Maintenance Disorders (Insomnia) 06/2009 - 04/2008
2	Psychomotor Agitation (Akathisia) 04/2008 - 05/2005
2	Drug-Related Side Effects and Adverse Reactions 11/2007 - 05/2007
2	Type 2 Diabetes Mellitus (MODY) 06/2004 - 04/2002
1	Ischemic Stroke 01/2022

Drug/Important Bio-Agent (IBA)

24	tofacitinibIBA 08/2022 - 02/2015
18	Pregabalin (Lyrica)FDA Link 01/2021 - 06/2009
17	Sildenafil Citrate (Viagra)FDA Link 04/2018 - 05/2003
11	Pharmaceutical PreparationsIBA 01/2022 - 05/2007
11	Janus Kinase InhibitorsIBA 01/2021 - 02/2015
9	Duloxetine Hydrochloride (Cymbalta)FDA Link 04/2015 - 11/2011
8	crisaboroleIBA 01/2022 - 07/2019
8	Opioid Analgesics (Opioids)IBA 01/2020 - 01/2014
7	Ointments (Pastes)IBA 01/2022 - 07/2019
7	Biological ProductsIBA 12/2021 - 07/2012
6	Adalimumab (Humira)FDA Link 08/2022 - 01/2019
6	Sunitinib (Sutent)FDA Link 06/2019 - 08/2008
5	Prostaglandins AIBA 08/2022 - 02/2015
5	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2020 - 01/2013
4	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021 - 01/2018
4	Tyrosine Kinase InhibitorsIBA 12/2020 - 01/2019
4	Axitinib (AG 013736)IBA 12/2018 - 01/2008
3	vedolizumabIBA 04/2022 - 09/2019
3	AnticoagulantsIBA 01/2022 - 01/2021
3	Phosphodiesterase 4 InhibitorsIBA 01/2022 - 07/2019
3	Gemtuzumab (Mylotarg)FDA Link 08/2021 - 02/2019
3	bosutinibIBA 01/2021 - 01/2019
3	Inotuzumab OzogamicinIBA 01/2020 - 01/2018
3	Antirheumatic Agents (DMARD)IBA 01/2020 - 04/2016
3	Celecoxib (Celebrex)FDA Link 01/2020 - 01/2011
3	Amitriptyline (Elavil)FDA LinkGeneric 02/2014 - 11/2011
3	Interferon-alpha (Interferon Alfa)IBA 06/2009 - 08/2008
3	Insulin (Novolin)FDA Link 01/2008 - 04/2002
2	abrocitinibIBA 10/2021 - 09/2021
2	nilotinib FDA Link 01/2021 - 01/2019
2	Janus KinasesIBA 01/2021 - 01/2018
2	golimumab FDA Link 01/2021 - 09/2019
2	glasdegibIBA 01/2021 - 10/2020
2	Dasatinib (BMS 354825)FDA Link 01/2021 - 01/2019
2	Infliximab (Remicade)FDA Link 01/2021 - 09/2019
2	PlatinumIBA 05/2020 - 01/2018
2	Tumor Necrosis Factor InhibitorsIBA 01/2020 - 09/2019
2	blinatumomabIBA 01/2020 - 01/2019
2	Analgesics (Analgesic Drugs)IBA 01/2019 - 06/2009
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2018 - 01/2008
2	bazedoxifeneIBA 10/2016 - 06/2014
2	Bupropion (Wellbutrin)FDA LinkGeneric 04/2012 - 04/2008
2	Varenicline (Chantix)FDA Link 04/2012 - 04/2008
2	amsonic acid (DAS)IBA 01/2009 - 10/2008
1	entrectinibIBA 06/2022
1	CrizotinibIBA 06/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2022
1	ametantrone (HAQ)IBA 01/2022
1	Methotrexate (Mexate)FDA LinkGeneric 01/2022
1	edoxabanIBA 01/2022
1	tanezumabIBA 01/2022

Therapy/Procedure

45	Therapeutics 05/2022 - 11/2006
8	Drug Therapy (Chemotherapy) 05/2022 - 01/2012
3	Aftercare (After-Treatment) 10/2020 - 06/2010
2	Length of Stay 10/2018 - 10/2011
2	Patient Readmission 02/2017 - 10/2011
2	Injections 11/2011 - 04/2002
2	Glycemic Control 06/2004 - 04/2002